🇺🇸 INFLUENZA B VIRUS, INACTIVATED NEURAMINIDASE in United States

INFLUENZA B VIRUS, INACTIVATED NEURAMINIDASE (INFLUENZA B VIRUS, INACTIVATED NEURAMINIDASE) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

INFLUENZA B VIRUS, INACTIVATED NEURAMINIDASE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is INFLUENZA B VIRUS, INACTIVATED NEURAMINIDASE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for INFLUENZA B VIRUS, INACTIVATED NEURAMINIDASE in United States?

Marketing authorisation holder not available in our data.